Ironwood Could Use Linzess As Model For GERD Market
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
The biotech has moved into mid-stage studies with a heartburn drug that will face OTC competition, much like Linzess has battled with in the area of constipation.